Empatho Holdings Inc. Announces Closing of Shares for Debt Settlement
Toronto, Ontario--(Newsfile Corp. - August 28, 2023) - Empatho Holdings Inc. (CSE: EMPH) (formerly, Shane Resources Ltd.) ("Empatho" or the...
Year: 2023
The Assistance Fund Opens New Program for Idiopathic Hypersomnia
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Idiopathic HypersomniaORLANDO, FL / ACCESSWIRE / August...
Making Connections To Care: Quest Supports Inspiring Health Equity Event Hosted by Sisters on the Vineyard
NORTHAMPTON, MA / ACCESSWIRE / August 28, 2023 / Quest DiagnosticsQuest Diagnostics supported the Health Empowerment and Wellness event hosted...
Alkermes Honors Women’s Equality Day
NORTHAMPTON, MA / ACCESSWIRE / August 28, 2023 / AlkermesEquality for women matters every day, and at Alkermes we're proud...
Planet 13 Enters into Definitive Agreement to Acquire VidaCann, Accelerating Its Florida Expansion Strategy
LAS VEGAS, NV / ACCESSWIRE / August 28, 2023 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),...
Nectar Life Sciences, the Health Technology Company Behind the First Hybrid, Vertically-Integrated Allergy Care Platform, Opens First Nectar Allergy Center in New York City
State-of-the-Art Clinic Expands Allergy Testing and Treatment from Online-Only to Hybrid With Brick and Mortar Presence, While New Medical Executives...
Megola Signs Remediation Deal with Stat Sanitizing
USA master distribution for leader in odor remediation servicesBONITA SPRINGS, FL / ACCESSWIRE / August 28, 2023 / (OTC PINK:MGON)...
Peregrine Health Services Adds Nationally Known Experts to Its Emergency Department, Trauma Center Consulting Team
Dr. Douglas Slakey and Michael S. Brown join the firm as strategic advisors to help emergency departments and trauma centers...
Jaguar Health to Present September 7 at Emerging Growth Conference and at the September 11-13 H.C. Wainwright Annual Global Investment Conference
Napo Pharmaceuticals, a Jaguar family company, reported completion August 17 of last patient last visit for its pivotal Phase 3...
Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
First digital-droplet PCR assay to receive coverageExpect initial revenue generation in Q1 2024IRVINE, CA / ACCESSWIRE / August 28, 2023...
GLUCOTRACK ANNOUNCES NEW VP OF MARKETING
Rutherford, NJ, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company...
Prominent Casana Executives Named to Prestigious American Heart Association Boards
Chief Operating Officer, Alongside Co-founder and Chief Research Officer, Assume Roles on AHA Boards in Rochester and BostonROCHESTER, N.Y., Aug....
Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism
CHARLOTTESVILLE, Va., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage...
T2 Biosystems Praises CDC’s Actions Aimed at Optimizing U.S. Hospital Sepsis Programs
The U.S. Centers for Disease Control and Prevention Releases 2023 Hospital Sepsis Program Core ElementsLEXINGTON, Mass., Aug. 28, 2023 (GLOBE...
NurExone Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Completed the first tranche of a non-brokered private placement offering of units for gross proceeds of approximately CAD$1.3 million to...
Fierce Biotech Names Cerevance a “Fierce 15” Biotech Company of 2023
BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel,...
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public...
Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference
MINNEAPOLIS, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the...
Novartis presents new long-term Leqvio® (inclisiran) data demonstrating consistent efficacy and safety beyond six years
Results from the ORION-8 open-label extension trial show twice-yearly* Leqvio, in addition to statin therapy, provides consistent low-density lipoprotein cholesterol...
ContraFect to Present at the World Anti-Microbial Resistance Congress 2023
YONKERS, N.Y., Aug. 28, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery...